Publications

5808 Results

Chemotherapy as predictor of compliance.

Authors
JR Jacobs;RR Casiano;DE Schuller;TF Pajak;GE Laramore;M Al-Sarraf
Journal / Conference
Journal of Surgical Oncology 55:143-148
Year
1994
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

The effect of perioperative blood transfusion on survival in head and neck cancer.

Authors
DE Schuller;C Scott;KM Wilson;R Freer;M Al-Sarraf;J Jacobs;K Ahmad;R Casiano;G Laramore
Journal / Conference
Archives of Otolaryngology-Head and Neck Surgery 120:711-716
Year
1994
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer: A Southwest Oncology Group study.

Authors
JO Atiba;SJ Green;HE Hynes;CK Osborne;TP Miller;M Davidner
Journal / Conference
Investigational New Drugs 12:129-132
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-8608

Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.

Authors
ME Marshall;B Blumenstein;ED Crawford;IM Thompson;JB Craig;M Eisenberger;F Ahmann
Journal / Conference
American Journal of Clinical Oncology 17(6):514-515
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8722

Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma: A Southwest Oncology Group study.

Authors
VK Malviya;PY Liu;R O'Toole;DS Alberts;E Surwit;S Rosenoff;JH Ward;A Yu;J O'Sullivan;JB Craig
Journal / Conference
AJCO 17(1):37-40
Year
1994
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8732

Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer.

Authors
CK Osborne;MC Sunderland;JA Neidhart;PM Ravdin;MD Abeloff
Journal / Conference
Annals of Oncology 5:43-47
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-8746

Phase II trial of 5-fluorouracil and high-dose folinic acid as first or second-line therapy for advanced breast cancer.

Authors
KA Margolin;S Green;K Osborne;JH Doroshow;SA Akman;LA Leong;RJ Morgan;JW Raschko;G Somlo;L Hutchins;C Upchurch
Journal / Conference
AJCO 17(2):173-180
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-8811

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell lung cancer: Results of phase II Southwest Oncology Group study.

Authors
MB Hazuka;JJ Crowley;PA Bunn Jr;M O'Rourke;TJ Braun;RB Livingston
Journal / Conference
Journal of Clinical Oncology 12(9):1814-1820
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-8836

GM-CSF, carboplatin, doxorubicin: a phase I study

Authors
EA Poplin;DS Alberts;JJ Rinehart;HO Smith;JA Neidhart;EM Hersh
Journal / Conference
Cancer Chemotherapy and Pharmacology 33:340-346
Year
1994
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8902

Phase II study of carboplatin (CBDCA) in refractory multiple myeloma: A Southwest Oncology Group study.

Authors
B Barlogie;J Crowley;SE Salmon;J Bonnet;JK Weick;K Hayden
Journal / Conference
Investigational New Drugs 12:53-55
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8944